Nanoform Finland Oyj NANOFH
OMXHEX · Finland · Health Technology
€0.8590-0.01 (-0.58%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Nanoform Finland PLC (FRA:4YL) achieves record first-quarter revenue and gross margin, signs a significant exclusivity deal, and progresses towards long-term business targets.
The European market recently experienced a volatile week, with the pan-European STOXX Europe 600 Index ending with modest gains amid easing geopolitical tensions and strong corporate earnings. In this context, investors are increasingly looking at penny stocks—typically smaller or newer companies—as potential opportunities for growth. Although the term "penny stocks" might seem outdated, these investments can still offer significant value when backed by strong financial health and a clear...
Nanoform Finland PLC (FRA:4YL) reports a record-breaking year with significant revenue growth, strategic global expansions, and promising advancements in nano farming technology.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.